Thursday, September 5, 2013
Publication and contact
Noninvasive, 3D imaging of
retinal and choroidal vasculature using phase-variance optical coherence
noninvasive method to image vasculature in the eye could help monitor
treatment responses and diagnose patients who have age-related macular degeneration
(AMD) and other choroidal vascular diseases. The method couples noninvasive,
high-resolution optical coherence tomography with phase variance-based
analysis to generate 3D images of vasculature and circulation in the retina
and three outermost layers of the choroid of the human eye. In the eye of a
patient with AMD who had geographic atrophy, the imaging method identified
vascular abnormalities in the retina and choroid and distinguished between
healthy and atrophic regions of the macula. Next steps could include using
the method to monitor treatment responses in patients who have AMD.
Published online Sept. 5, 2013
Patent and licensing status
Kim, D.Y. et al. Proc.
Natl. Acad. Sci. USA; published online Aug. 5, 2013;
Contact: John S. Werner, University of California, Davis,
Contact: Scott E. Fraser, California Institute of
Technology, Pasadena, Calif.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]